Literature DB >> 19181113

XPG: its products and biological roles.

Orlando D Schärer1.   

Abstract

Xeroderma pigmetosum patients of the complementation group G are rare. One group of XP-G patients displays a rather mild and typical XP phenotype. Mutations in these patients interfere with the function of XPG in the nucleotide excision repair, where it has a structural role in the assembly of the preincision complex and a catalytic role in making the incision 3' to the damaged site in DNA. Another set of XP-G patient is much more severely affected, displaying combined symptoms of xeroderma pigmentosum and Cockayne syndrome, referred to as XP/CS complex. Although the molecular basis leading to the XP/CS complex has not yet been fully established, current evidence suggests that these patients suffer from a mild defect in transcription in addition to a repair defect. Here, the history of how the XPG gene was discovered, the biochemical properties of the XPG protein and the molecular defects found in XP-G patients and mouse models are reviewed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19181113      PMCID: PMC2721477          DOI: 10.1007/978-0-387-09599-8_9

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  66 in total

1.  The comings and goings of nucleotide excision repair factors on damaged DNA.

Authors:  Thilo Riedl; Fumio Hanaoka; Jean-Marc Egly
Journal:  EMBO J       Date:  2003-10-01       Impact factor: 11.598

2.  The XPG story.

Authors:  S G Clarkson
Journal:  Biochimie       Date:  2003-11       Impact factor: 4.079

3.  Structural determinants for substrate binding and catalysis by the structure-specific endonuclease XPG.

Authors:  Marcel Hohl; Fabrizio Thorel; Stuart G Clarkson; Orlando D Schärer
Journal:  J Biol Chem       Date:  2003-03-18       Impact factor: 5.157

4.  Ordered conformational changes in damaged DNA induced by nucleotide excision repair factors.

Authors:  Angels Tapias; Jerome Auriol; Diane Forget; Jacqueline H Enzlin; Orlando D Schärer; Frederic Coin; Benoit Coulombe; Jean-Marc Egly
Journal:  J Biol Chem       Date:  2004-02-23       Impact factor: 5.157

5.  Genetic heterogeneity of xeroderma pigmentosum demonstrated by somatic cell hybridization.

Authors:  E A De Weerd-Kastelein; W Keijzer; D Bootsma
Journal:  Nat New Biol       Date:  1972-07-19

6.  Defective repair replication of DNA in xeroderma pigmentosum.

Authors:  J E Cleaver
Journal:  Nature       Date:  1968-05-18       Impact factor: 49.962

7.  Xeroderma pigmentosum--a unique variant with neurological involvement.

Authors:  M J Chessbrough
Journal:  Br J Dermatol       Date:  1978-07       Impact factor: 9.302

8.  Identification of the XPG region that causes the onset of Cockayne syndrome by using Xpg mutant mice generated by the cDNA-mediated knock-in method.

Authors:  Naoko Shiomi; Seiji Kito; Masaki Oyama; Tsukasa Matsunaga; Yoshi-Nobu Harada; Masahito Ikawa; Masaru Okabe; Tadahiro Shiomi
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

9.  Deficiency in the nuclease activity of xeroderma pigmentosum G in mice leads to hypersensitivity to UV irradiation.

Authors:  Ming Tian; David A Jones; Michele Smith; Reiko Shinkura; Frederick W Alt
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

Review 10.  Flap endonuclease 1: a central component of DNA metabolism.

Authors:  Yuan Liu; Hui-I Kao; Robert A Bambara
Journal:  Annu Rev Biochem       Date:  2004       Impact factor: 23.643

View more
  32 in total

1.  Multiple DNA binding domains mediate the function of the ERCC1-XPF protein in nucleotide excision repair.

Authors:  Yan Su; Barbara Orelli; Advaitha Madireddy; Laura J Niedernhofer; Orlando D Schärer
Journal:  J Biol Chem       Date:  2012-04-30       Impact factor: 5.157

2.  The DNA repair endonuclease XPG interacts directly and functionally with the WRN helicase defective in Werner syndrome.

Authors:  Kelly S Trego; Sophia B Chernikova; Albert R Davalos; J Jefferson P Perry; L David Finger; Cliff Ng; Miaw-Sheue Tsai; Steven M Yannone; John A Tainer; Judith Campisi; Priscilla K Cooper
Journal:  Cell Cycle       Date:  2011-06-15       Impact factor: 4.534

Review 3.  GEN1/Yen1 and the SLX4 complex: Solutions to the problem of Holliday junction resolution.

Authors:  Jennifer M Svendsen; J Wade Harper
Journal:  Genes Dev       Date:  2010-03-04       Impact factor: 11.361

Review 4.  DNA repair mechanisms in dividing and non-dividing cells.

Authors:  Teruaki Iyama; David M Wilson
Journal:  DNA Repair (Amst)       Date:  2013-05-16

Review 5.  Understanding nucleotide excision repair and its roles in cancer and ageing.

Authors:  Jurgen A Marteijn; Hannes Lans; Wim Vermeulen; Jan H J Hoeijmakers
Journal:  Nat Rev Mol Cell Biol       Date:  2014-07       Impact factor: 94.444

Review 6.  Oxidative and energy metabolism as potential clues for clinical heterogeneity in nucleotide excision repair disorders.

Authors:  Mohsen Hosseini; Khaled Ezzedine; Alain Taieb; Hamid R Rezvani
Journal:  J Invest Dermatol       Date:  2014-10-09       Impact factor: 8.551

7.  Role of interaction of XPF with RPA in nucleotide excision repair.

Authors:  Laura A Fisher; Mika Bessho; Mitsuo Wakasugi; Tsukasa Matsunaga; Tadayoshi Bessho
Journal:  J Mol Biol       Date:  2011-08-22       Impact factor: 5.469

8.  Regulation of Transcription Elongation by the XPG-TFIIH Complex Is Implicated in Cockayne Syndrome.

Authors:  Takashi Narita; Keiko Narita; Arato Takedachi; Masafumi Saijo; Kiyoji Tanaka
Journal:  Mol Cell Biol       Date:  2015-07-06       Impact factor: 4.272

9.  Cdt2-mediated XPG degradation promotes gap-filling DNA synthesis in nucleotide excision repair.

Authors:  Chunhua Han; Gulzar Wani; Ran Zhao; Jiang Qian; Nidhi Sharma; Jinshan He; Qianzheng Zhu; Qi-En Wang; Altaf A Wani
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

10.  Expression of XPG protein in human normal and tumor tissues.

Authors:  Miguel Aracil; Lisa M Dauffenbach; Marta Martínez Diez; Rana Richeh; Victoria Moneo; Juan Fernando Martínez Leal; Luis Francisco García Fernández; Christopher A Kerfoot; Carlos M Galmarini
Journal:  Int J Clin Exp Pathol       Date:  2013-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.